Diagnostic Approach for Gammopathy

Initial Diagnostic Tests

The diagnostic workup for gammopathy should include serum protein electrophoresis, serum immunofixation, and serum free light chain assay as the primary tests, with 24-hour urine protein electrophoresis and immunofixation as complementary studies 1, 2
Serum Protein Electrophoresis (SPEP) is a first-line test that is quantitative, easy to perform, and inexpensive; it identifies monoclonal protein as a homogeneous spike-like peak in the gamma-globulin zone 1, 2
Serum Immunofixation (IFE) is more sensitive than SPEP and necessary for identification and typing of monoclonal immunoglobulins; it should be performed even if SPEP is negative when clinical suspicion is high 1, 2
Serum Free Light Chain Assay is a critical test that measures κ and λ free light chains independently and determines the κ:λ ratio; clonality can be inferred from an abnormal ratio (high ratio indicates κ clone, low ratio indicates λ clone) 1, 3

Bone Marrow Aspirate/Biopsy is required when multiple myeloma is suspected; diagnosis is confirmed when >10% clonal plasma cells are detected 2
Cytogenetics, including standard metaphase cytogenetics and FISH, provide important prognostic information 2
Immunoblotting is a highly sensitive technique that can detect small amounts of monoclonal immunoglobulin and characterize IgG heavy-chain subclasses; however, it is not widely available 1, 3

Free Light Chain Interpretation: Renal function affects free light chain concentration; 'normal' κ:λ ratio (0.26-1.65) can rise to 0.34-3.10 in severe renal impairment 3, 4
Assay Consistency: Different free light chain assays (e.g., N Latex vs. FreeLite) are not mathematically convertible; the same assay must be used throughout patient monitoring 3, 5
Renal impairment affects free light chain levels and ratios; interpretation must account for kidney function 3, 4

The National Comprehensive Cancer Network recommends that the serum free light chain (FLC) assay significantly improves detection of monoclonal gammopathies when used alongside SPEP and SIFE, particularly for light chain disorders 6, 7
Approximately 3% of patients with plasma cell disorders have non-secretory disease with neither serum nor urine proteins detectable by conventional electrophoresis, as stated by the National Comprehensive Cancer Network 8
Light chain MGUS may be missed by SPEP alone, as these patients have abnormal free light chain ratios without detectable M-proteins on SPEP, according to Haematologica 7

The National Comprehensive Cancer Network recommends that the optimal diagnostic panel for suspected monoclonal gammopathies should include SPEP, SIFE, and serum FLC assay 6, 7
24-hour urine protein electrophoresis (UPEP) and urine immunofixation electrophoresis (UIFE) are recommended as complementary studies to detect Bence Jones proteinuria, as suggested by the National Comprehensive Cancer Network 6, 8
Bone marrow examination is not routinely recommended for asymptomatic patients with apparent IgG MGUS if the serum M-protein is ≤15 g/L and there is no end-organ damage, according to Haematologica 7
For IgA and IgM M-proteins, bone marrow examination should be part of the diagnostic workup regardless of concentration, as recommended by Haematologica 7

Not including serum FLC assay in the initial workup, which can miss light chain disorders, is a common pitfall, as stated by the National Comprehensive Cancer Network and Haematologica 6, 7